 |
|
The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies
Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, Takayuki Goto, Takashi Kobayashi
J Urol Oncol. 2023;21(1):23-31. Published online 2023 Mar 31 DOI: https://doi.org/10.22465/juo.234600060003
|
|
Citations to this article as recorded by
 First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States
Rana R. McKay, Alicia K. Morgans, Neal D. Shore, Curtis Dunshee, Geeta Devgan, Neeraj Agarwal
Cancer Treatment Reviews.2024; 126: 102726. CrossRef
|